Georg Lenz

Active 1999–2025

140
Papers
22,939
Citations
64
h-index
129
i10-index

Citations

Citations per year for Georg Lenz1991: 1 citations1993: 1 citations1996: 3 citations1999: 1 citations2000: 5 citations2001: 2 citations2002: 11 citations2003: 13 citations2004: 6 citations2005: 20 citations2006: 31 citations2007: 51 citations2008: 85 citations2009: 141 citations2010: 222 citations2011: 306 citations2012: 345 citations2013: 305 citations2014: 322 citations2015: 320 citations2016: 230 citations2017: 203 citations2018: 247 citations2019: 714 citations2020: 687 citations2021: 666 citations2022: 560 citations2023: 500 citations2024: 882 citations2025: 392 citations2026: 13 citations1992: no citations, so this year is not shown1994–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,384 citing papers, 25.8% of this breakdownChina: 888 citing papers, 9.6% of this breakdownGermany: 769 citing papers, 8.3% of this breakdownUnited Kingdom: 573 citing papers, 6.2% of this breakdownItaly: 512 citing papers, 5.5% of this breakdownFrance: 448 citing papers, 4.9% of this breakdownCanada: 381 citing papers, 4.1% of this breakdownSpain: 364 citing papers, 3.9% of this breakdownSwitzerland: 320 citing papers, 3.5% of this breakdownJapan: 226 citing papers, 2.5% of this breakdownNetherlands: 222 citing papers, 2.4% of this breakdownAustralia: 194 citing papers, 2.1% of this breakdown
0%25.8%Other 21.2%

Fields

  • Medicine60.8%
  • Biochemistry, Genetics and Molecular Biology27.2%
  • Immunology and Microbiology9.9%
  • Computer Science0.6%
  • Neuroscience0.3%
  • Engineering0.2%
  • Other1%

Topics

  • Lymphoma Diagnosis and Treatment14.3%
  • Chronic Lymphocytic Leukemia Research6.3%
  • CAR-T cell therapy research4.4%
  • Immune Cell Function and Interaction3.8%
  • Viral-associated cancers and disorders3.7%
  • CNS Lymphoma Diagnosis and Treatment2.5%
  • Other65%

Coauthors

All papers

Open in search
  1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 cited by 1,506

  2. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rita M. Braziel, Raymond R. Tubbs, James R. Cook, Dennis D. Weisenburger, Wing C. Chan, Susan K. Pierce, Louis M. Staudt - Nature 2010 cited by 1,663

  3. Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2021 cited by 186

  4. Stromal Gene Signatures in Large-B-Cell Lymphomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emili Montserrat, Elı́as Campo, Rita M. Braziel, Thomas P. Miller, Lisa M. Rimsza, James R. Cook, Brad Pohlman, John Sweetenham, Raymond R. Tubbs, Richard I. Fisher, Elena Hartmann, Andreas Rosenwald, German Ott, Müller-Hermelink Hk, David Wrench, T. Lister, Elaine S. Jaffe, Wyndham H. Wilson, Wing C. Chan, Louis M. Staudt - New England Journal of Medicine 2008 cited by 1,818

  5. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yuhong Fan, Rudolf Grosschedl, Claude Chelala, Jude Fitzgibbon - Nature Genetics 2013 cited by 731

  6. Genomic profiling for clinical decision making in lymphoid neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfgang Hiddemann, Won Seog Kim, Rebecca L. King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, José I. Martín‐Subero, Miguel Á. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla‐Martínez, Scott J. Rodig, Andreas Rosenwald, Gilles Salles, Jesús F. San Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott - Blood 2022 cited by 161

  7. Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 1,260

  8. Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Randy D. Gascoyne - Journal of Clinical Oncology 2012 cited by 973

  9. BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis

    Authors: , , , , , , , , , , , , , , , , , , , - Blood 2023 cited by 62

  10. Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 398

  11. Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome–Negative B-Precursor ALL

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 77

  12. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 985

  13. Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2008 cited by 880

  14. Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2013 cited by 332

  15. Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2007 cited by 949

  16. The whole-genome landscape of Burkitt lymphoma subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Micah A. Luftig, Alexander Waldrop, Tushar Dave, Devang Thakkar, Harshit Sahay, Guojie Li, Brooke C. Palus, Vidya Seshadri, So Young Kim, Randy D. Gascoyne, Shawn Levy, Minerva Mukhopadyay, David B. Dunson, Sandeep S. Davé - Blood 2019 cited by 200

  17. Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2015 cited by 152

  18. A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2020 cited by 97

  19. Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma

    Authors: , , - Blood 2021 cited by 73

  20. Molecular profiling of EBV associated diffuse large B-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Leukemia 2023 cited by 72

  21. Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elihu H. Estey, Carole Shaw, Rita Exeler, Lisa Wagenführ, Friedrich Stölzel, Christian Thiede, Matthias Stelljes, Georg Lenz, Jan-Henrik Mikesch, Hubert Serve, Gerhard Ehninger, Wolfgang E. Berdel, Michael Krämer, Utz Krug, Christoph Schliemann - Journal of Clinical Oncology 2019 cited by 116

  22. Liquid Biopsies in Lung Cancer

    Authors: , , , , , , - Cancers 2023 cited by 41

  23. Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study

    Authors: , , , , , , , , , , , , , , , , , - HemaSphere 2024 cited by 33

  24. Clinical Impact of the Cell-of-Origin Classification and the MYC / BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 219